vaccines

Pfizer Launches Global Centers of Excellence Network for Vaccine Research
Pfizer Launches Global Centers of Excellence Network for Vaccine Research
BioSpace
Pfizer
vaccines
drug development
Flag link:
GSK hands TB vaccine to Gates Foundation's nonprofit biotech
GSK hands TB vaccine to Gates Foundation's nonprofit biotech
Fierce Biotech
GSK
tuberculosis
vaccines
Bill Gates
Gates Foundation
M72/AS01E
Flag link:
J&J jumping in on coronavirus vax work as disease continues its spread
J&J jumping in on coronavirus vax work as disease continues its spread
Fierce Biotech
JNJ
vaccines
Wuhan Coronavirus
Gilead Sciences
Moderna Therapeutics
Flag link:
Moderna, federal researchers kick off vaccine work against deadly new coronavirus
Moderna, federal researchers kick off vaccine work against deadly new coronavirus
Fierce Pharma
Moderna Therapeutics
MRNA
Wuhan Coronavirus
vaccines
NIH
Flag link:
Merck turns to contract manufacturers to help with Gardasil supply, plans 2023 plant openings
Merck turns to contract manufacturers to help with Gardasil supply, plans 2023 plant openings
Fierce Pharma
Merck
Ken Frazier
Pharma CEOs
JPMHC 2020
Gardasil
vaccines
drug manufacturing
Flag link:
Wuhan Coronavirus Hits the U.S. And Vaccine Stock Soars
Wuhan Coronavirus Hits the U.S. And Vaccine Stock Soars
Motley Fool
Wuhan Coronavirus
China
CDC
vaccines
Novavax
Flag link:
JPM: Glaxo sees enormous Shingrix potential, but a supply gap still stands in the way
JPM: Glaxo sees enormous Shingrix potential, but a supply gap still stands in the way
Fierce Pharma
GSK
vaccines
Shingrix
shingles
drug shortages
JPMHC 2020
Flag link:
Novavax Wins Fast-Track Designation for Flu Vaccine
Novavax Wins Fast-Track Designation for Flu Vaccine
Motley Fool
Novavax
flu vaccines
vaccines
NanoFlu
FDA
fast track
Flag link:
We May Be One Step Closer To A Vaccine Against Alzheimer’s Disease
We May Be One Step Closer To A Vaccine Against Alzheimer’s Disease
Forbes
vaccines
Alzheimer's disease
Flag link:
Vaccination Rates Rise In California After Personal Belief Exemptions Curbed
Vaccination Rates Rise In California After Personal Belief Exemptions Curbed
Forbes
California
vaccines
Flag link:
Lyme Disease Vaccine Could Be Ready In 4 to 5 Years
Lyme Disease Vaccine Could Be Ready In 4 to 5 Years
Forbes
Lyme disease
vaccines
Valneva
VLA015
Flag link:
VBI Vaccines announces second pivotal phase 3 study of Sci-B-Vac meets primary and secondary endpoints
VBI Vaccines announces second pivotal phase 3 study of Sci-B-Vac meets primary and secondary endpoints
Pharmaceutical Business Review
VBI Vaccines
vaccines
clinical trials
Sci-B-Vac
ARO-HBV
Flag link:
Moderna, though early in development, prepares its vaccine for market
Moderna, though early in development, prepares its vaccine for market
BioPharma Dive
Moderna Therapeutics
CMV
vaccines
Flag link:
‘Against all odds’: The inside story of how scientists across three continents produced an Ebola vaccine
‘Against all odds’: The inside story of how scientists across three continents produced an Ebola vaccine
Stat
ebola virus
vaccines
WHO
Merck
Flag link:
Homegrown rivals to Pfizer, Merck cash cow vaccines win nods in China
Homegrown rivals to Pfizer, Merck cash cow vaccines win nods in China
Fierce Pharma
Pfizer
Merck
Prevnar 13
Gardasil
vaccines
China
Walvax
Flag link:
GSK closes sale of two vaccine brands to Bavarian Nordic
GSK closes sale of two vaccine brands to Bavarian Nordic
Pharmaceutical Business Review
GSK
vaccines
Bavarian Nordic
Rabipur
Encepur
travel vaccines
Flag link:
3 challenges to watch in global health in 2020
3 challenges to watch in global health in 2020
Stat
global health
polio
dengue
vaccines
viral infections
Flag link:
FDA approves an Ebola vaccine, long in development, for the first time
FDA approves an Ebola vaccine, long in development, for the first time
Stat
FDA
Merck
vaccines
Ebola
Flag link:
Gritstone posts 'one of the most potent immunogenic-responses for a neoantigen vaccine'
Gritstone posts 'one of the most potent immunogenic-responses for a neoantigen vaccine'
Fierce Biotech
Gritstone Oncology
solid tumors
vaccines
neoantigens
Flag link:
Pfizer to debut podcast series around vaccines, probing scientific, cultural and political issues
Pfizer to debut podcast series around vaccines, probing scientific, cultural and political issues
Fierce Pharma
Pfizer
vaccines
podcasts
drug marketing
Flag link:

Pages